Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI
NCT03118830Phase 4Completed
- Sponsor
- Cairo University
- Start
- Apr 2017
- Primary completion
- Nov 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of triptorelin and cetrorelix in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Cairo University. Primary endpoint: Clinical Pregnancy Rate. Started Apr 2017; status: completed.
02
Drugs
triptorelincetrorelix
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03118830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03118830.